Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium oxide versus senna for chronic constipation
IRCT20241125063845N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in chronic constipation comparing Magnesium oxide group with Senna group (2 arms). Primary endpoints: Frequency of bowel movements, Stool consistency and 1 more. Started Jan 2025; status: completed.
02
Drugs
magnesium oxidesennosides
03
Conditions
chronic constipation
Beyond the preview
Go deeper on IRCT20241125063845N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241125063845N1.